nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—ADRA2A—epilepsy syndrome	0.384	0.63	CbGaD
Oxymetazoline—HTR2A—epilepsy syndrome	0.225	0.37	CbGaD
Oxymetazoline—HTR1D—meninx—epilepsy syndrome	0.0179	0.13	CbGeAlD
Oxymetazoline—HTR2A—phrenic nerve—epilepsy syndrome	0.00963	0.0698	CbGeAlD
Oxymetazoline—HTR2A—locus ceruleus—epilepsy syndrome	0.0043	0.0312	CbGeAlD
Oxymetazoline—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00424	0.0308	CbGeAlD
Oxymetazoline—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00411	0.0298	CbGeAlD
Oxymetazoline—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00407	0.0295	CbGeAlD
Oxymetazoline—HTR2A—cerebellar cortex—epilepsy syndrome	0.00351	0.0254	CbGeAlD
Oxymetazoline—HTR2A—vagus nerve—epilepsy syndrome	0.00329	0.0239	CbGeAlD
Oxymetazoline—Xylometazoline—ADRA2A—epilepsy syndrome	0.0032	1	CrCbGaD
Oxymetazoline—HTR1B—ganglion—epilepsy syndrome	0.00264	0.0191	CbGeAlD
Oxymetazoline—HTR1D—ganglion—epilepsy syndrome	0.00256	0.0185	CbGeAlD
Oxymetazoline—HTR2C—ganglion—epilepsy syndrome	0.00253	0.0184	CbGeAlD
Oxymetazoline—HTR2A—pons—epilepsy syndrome	0.00248	0.018	CbGeAlD
Oxymetazoline—HTR1E—brainstem—epilepsy syndrome	0.00243	0.0176	CbGeAlD
Oxymetazoline—HTR1E—forebrain—epilepsy syndrome	0.00234	0.017	CbGeAlD
Oxymetazoline—HTR2A—autonomic nervous system—epilepsy syndrome	0.00229	0.0166	CbGeAlD
Oxymetazoline—HTR1E—telencephalon—epilepsy syndrome	0.00215	0.0156	CbGeAlD
Oxymetazoline—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00204	0.0148	CbGeAlD
Oxymetazoline—NISCH—telencephalon—epilepsy syndrome	0.00158	0.0115	CbGeAlD
Oxymetazoline—ADRA1A—hindbrain—epilepsy syndrome	0.00149	0.0108	CbGeAlD
Oxymetazoline—ADRA1D—forebrain—epilepsy syndrome	0.00144	0.0104	CbGeAlD
Oxymetazoline—HTR1E—head—epilepsy syndrome	0.00134	0.00972	CbGeAlD
Oxymetazoline—ADRA1D—telencephalon—epilepsy syndrome	0.00132	0.00957	CbGeAlD
Oxymetazoline—HTR1E—nervous system—epilepsy syndrome	0.00127	0.00922	CbGeAlD
Oxymetazoline—HTR2A—ganglion—epilepsy syndrome	0.00127	0.00921	CbGeAlD
Oxymetazoline—NISCH—medulla oblongata—epilepsy syndrome	0.00124	0.00901	CbGeAlD
Oxymetazoline—HTR1E—central nervous system—epilepsy syndrome	0.00122	0.00888	CbGeAlD
Oxymetazoline—HTR1B—brainstem—epilepsy syndrome	0.00115	0.00832	CbGeAlD
Oxymetazoline—NISCH—midbrain—epilepsy syndrome	0.00114	0.00823	CbGeAlD
Oxymetazoline—HTR1D—brainstem—epilepsy syndrome	0.00111	0.00806	CbGeAlD
Oxymetazoline—HTR1B—forebrain—epilepsy syndrome	0.00111	0.00803	CbGeAlD
Oxymetazoline—NISCH—spinal cord—epilepsy syndrome	0.00111	0.00803	CbGeAlD
Oxymetazoline—HTR2C—brainstem—epilepsy syndrome	0.0011	0.00798	CbGeAlD
Oxymetazoline—HTR1D—forebrain—epilepsy syndrome	0.00107	0.00778	CbGeAlD
Oxymetazoline—HTR2C—forebrain—epilepsy syndrome	0.00106	0.0077	CbGeAlD
Oxymetazoline—HTR1B—telencephalon—epilepsy syndrome	0.00102	0.00739	CbGeAlD
Oxymetazoline—HTR2B—forebrain—epilepsy syndrome	0.000998	0.00723	CbGeAlD
Oxymetazoline—HTR1D—telencephalon—epilepsy syndrome	0.000986	0.00715	CbGeAlD
Oxymetazoline—HTR2C—telencephalon—epilepsy syndrome	0.000977	0.00708	CbGeAlD
Oxymetazoline—HTR1E—brain—epilepsy syndrome	0.000972	0.00705	CbGeAlD
Oxymetazoline—HTR2A—hindbrain—epilepsy syndrome	0.000963	0.00698	CbGeAlD
Oxymetazoline—HTR2B—telencephalon—epilepsy syndrome	0.000918	0.00665	CbGeAlD
Oxymetazoline—NISCH—cerebellum—epilepsy syndrome	0.000878	0.00637	CbGeAlD
Oxymetazoline—ADRA1A—brainstem—epilepsy syndrome	0.000854	0.00619	CbGeAlD
Oxymetazoline—ADRA1B—head—epilepsy syndrome	0.00084	0.00609	CbGeAlD
Oxymetazoline—ADRA1A—forebrain—epilepsy syndrome	0.000824	0.00598	CbGeAlD
Oxymetazoline—ADRA1D—head—epilepsy syndrome	0.000822	0.00596	CbGeAlD
Oxymetazoline—ADRA1B—nervous system—epilepsy syndrome	0.000796	0.00577	CbGeAlD
Oxymetazoline—ADRA1D—nervous system—epilepsy syndrome	0.000779	0.00565	CbGeAlD
Oxymetazoline—HTR2C—medulla oblongata—epilepsy syndrome	0.000768	0.00556	CbGeAlD
Oxymetazoline—ADRA1B—central nervous system—epilepsy syndrome	0.000767	0.00556	CbGeAlD
Oxymetazoline—ADRA1A—telencephalon—epilepsy syndrome	0.000758	0.00549	CbGeAlD
Oxymetazoline—ADRA1D—central nervous system—epilepsy syndrome	0.00075	0.00544	CbGeAlD
Oxymetazoline—HTR1B—midbrain—epilepsy syndrome	0.000732	0.0053	CbGeAlD
Oxymetazoline—ADRA2C—telencephalon—epilepsy syndrome	0.000722	0.00524	CbGeAlD
Oxymetazoline—HTR1B—spinal cord—epilepsy syndrome	0.000714	0.00517	CbGeAlD
Oxymetazoline—NISCH—brain—epilepsy syndrome	0.000714	0.00517	CbGeAlD
Oxymetazoline—HTR1D—midbrain—epilepsy syndrome	0.000708	0.00514	CbGeAlD
Oxymetazoline—HTR2C—midbrain—epilepsy syndrome	0.000702	0.00509	CbGeAlD
Oxymetazoline—HTR2C—spinal cord—epilepsy syndrome	0.000684	0.00496	CbGeAlD
Oxymetazoline—HTR1B—head—epilepsy syndrome	0.000634	0.0046	CbGeAlD
Oxymetazoline—ADRA2A—forebrain—epilepsy syndrome	0.000627	0.00454	CbGeAlD
Oxymetazoline—HTR1D—head—epilepsy syndrome	0.000614	0.00445	CbGeAlD
Oxymetazoline—ADRA1B—brain—epilepsy syndrome	0.000609	0.00441	CbGeAlD
Oxymetazoline—HTR2C—head—epilepsy syndrome	0.000608	0.00441	CbGeAlD
Oxymetazoline—HTR1B—nervous system—epilepsy syndrome	0.000602	0.00436	CbGeAlD
Oxymetazoline—ADRA1D—brain—epilepsy syndrome	0.000595	0.00432	CbGeAlD
Oxymetazoline—HTR1D—nervous system—epilepsy syndrome	0.000582	0.00422	CbGeAlD
Oxymetazoline—HTR1B—central nervous system—epilepsy syndrome	0.000579	0.0042	CbGeAlD
Oxymetazoline—HTR2C—nervous system—epilepsy syndrome	0.000577	0.00418	CbGeAlD
Oxymetazoline—ADRA2A—telencephalon—epilepsy syndrome	0.000576	0.00418	CbGeAlD
Oxymetazoline—HTR2B—head—epilepsy syndrome	0.000571	0.00414	CbGeAlD
Oxymetazoline—ADRA2C—medulla oblongata—epilepsy syndrome	0.000567	0.00411	CbGeAlD
Oxymetazoline—HTR1D—central nervous system—epilepsy syndrome	0.000561	0.00406	CbGeAlD
Oxymetazoline—HTR2C—central nervous system—epilepsy syndrome	0.000555	0.00402	CbGeAlD
Oxymetazoline—HTR2A—brainstem—epilepsy syndrome	0.000552	0.004	CbGeAlD
Oxymetazoline—HTR2B—nervous system—epilepsy syndrome	0.000542	0.00393	CbGeAlD
Oxymetazoline—HTR2A—forebrain—epilepsy syndrome	0.000533	0.00386	CbGeAlD
Oxymetazoline—HTR2B—central nervous system—epilepsy syndrome	0.000522	0.00378	CbGeAlD
Oxymetazoline—ADRA2C—midbrain—epilepsy syndrome	0.000519	0.00376	CbGeAlD
Oxymetazoline—ADRA2C—spinal cord—epilepsy syndrome	0.000506	0.00367	CbGeAlD
Oxymetazoline—HTR2A—telencephalon—epilepsy syndrome	0.00049	0.00355	CbGeAlD
Oxymetazoline—ADRA1A—head—epilepsy syndrome	0.000472	0.00342	CbGeAlD
Oxymetazoline—HTR1B—brain—epilepsy syndrome	0.00046	0.00333	CbGeAlD
Oxymetazoline—ADRA2A—medulla oblongata—epilepsy syndrome	0.000453	0.00328	CbGeAlD
Oxymetazoline—ADRA2C—head—epilepsy syndrome	0.00045	0.00326	CbGeAlD
Oxymetazoline—ADRA1A—nervous system—epilepsy syndrome	0.000447	0.00324	CbGeAlD
Oxymetazoline—HTR1D—brain—epilepsy syndrome	0.000445	0.00323	CbGeAlD
Oxymetazoline—HTR2C—brain—epilepsy syndrome	0.000441	0.0032	CbGeAlD
Oxymetazoline—ADRA1A—central nervous system—epilepsy syndrome	0.000431	0.00312	CbGeAlD
Oxymetazoline—ADRA2C—nervous system—epilepsy syndrome	0.000426	0.00309	CbGeAlD
Oxymetazoline—ADRA1A—cerebellum—epilepsy syndrome	0.000421	0.00305	CbGeAlD
Oxymetazoline—HTR2B—brain—epilepsy syndrome	0.000414	0.003	CbGeAlD
Oxymetazoline—ADRA2A—midbrain—epilepsy syndrome	0.000414	0.003	CbGeAlD
Oxymetazoline—ADRA2C—central nervous system—epilepsy syndrome	0.000411	0.00298	CbGeAlD
Oxymetazoline—ADRA2A—spinal cord—epilepsy syndrome	0.000404	0.00293	CbGeAlD
Oxymetazoline—ADRA2C—cerebellum—epilepsy syndrome	0.000401	0.00291	CbGeAlD
Oxymetazoline—HTR2A—medulla oblongata—epilepsy syndrome	0.000385	0.00279	CbGeAlD
Oxymetazoline—ADRA2A—head—epilepsy syndrome	0.000359	0.0026	CbGeAlD
Oxymetazoline—HTR2A—midbrain—epilepsy syndrome	0.000352	0.00255	CbGeAlD
Oxymetazoline—HTR2A—spinal cord—epilepsy syndrome	0.000343	0.00249	CbGeAlD
Oxymetazoline—ADRA1A—brain—epilepsy syndrome	0.000342	0.00248	CbGeAlD
Oxymetazoline—ADRA2A—nervous system—epilepsy syndrome	0.00034	0.00247	CbGeAlD
Oxymetazoline—ADRA2A—central nervous system—epilepsy syndrome	0.000328	0.00237	CbGeAlD
Oxymetazoline—ADRA2C—brain—epilepsy syndrome	0.000326	0.00236	CbGeAlD
Oxymetazoline—ADRA2A—cerebellum—epilepsy syndrome	0.00032	0.00232	CbGeAlD
Oxymetazoline—HTR2A—head—epilepsy syndrome	0.000305	0.00221	CbGeAlD
Oxymetazoline—HTR2A—nervous system—epilepsy syndrome	0.000289	0.0021	CbGeAlD
Oxymetazoline—HTR2A—central nervous system—epilepsy syndrome	0.000279	0.00202	CbGeAlD
Oxymetazoline—HTR2A—cerebellum—epilepsy syndrome	0.000272	0.00197	CbGeAlD
Oxymetazoline—ADRA2A—brain—epilepsy syndrome	0.00026	0.00189	CbGeAlD
Oxymetazoline—HTR2A—brain—epilepsy syndrome	0.000221	0.0016	CbGeAlD
Oxymetazoline—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	5.94e-06	2.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	5.94e-06	2.38e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	5.94e-06	2.38e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	5.93e-06	2.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	5.93e-06	2.38e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	5.92e-06	2.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	5.92e-06	2.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	5.91e-06	2.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	5.89e-06	2.36e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	5.88e-06	2.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	5.86e-06	2.35e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	5.82e-06	2.33e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	5.81e-06	2.33e-05	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—SRC—epilepsy syndrome	5.77e-06	2.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—GPX1—epilepsy syndrome	5.76e-06	2.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	5.76e-06	2.31e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	5.76e-06	2.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	5.75e-06	2.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	5.73e-06	2.3e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	5.7e-06	2.28e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	5.67e-06	2.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	5.66e-06	2.27e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	5.63e-06	2.26e-05	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—VEGFA—epilepsy syndrome	5.62e-06	2.25e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	5.6e-06	2.25e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	5.59e-06	2.24e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	5.58e-06	2.24e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	5.57e-06	2.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	5.56e-06	2.23e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	5.56e-06	2.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	5.54e-06	2.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	5.54e-06	2.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	5.52e-06	2.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	5.51e-06	2.21e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	5.48e-06	2.2e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	5.46e-06	2.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	5.45e-06	2.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	5.44e-06	2.18e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	5.4e-06	2.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	5.39e-06	2.16e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	5.39e-06	2.16e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	5.38e-06	2.16e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	5.36e-06	2.15e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	5.35e-06	2.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	5.35e-06	2.14e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	5.34e-06	2.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	5.34e-06	2.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	5.29e-06	2.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	5.27e-06	2.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	5.26e-06	2.11e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	5.25e-06	2.1e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	5.24e-06	2.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—POMC—epilepsy syndrome	5.23e-06	2.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	5.2e-06	2.09e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	5.2e-06	2.08e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.2e-06	2.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	5.19e-06	2.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	5.17e-06	2.07e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	5.14e-06	2.06e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	5.14e-06	2.06e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	5.13e-06	2.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	5.12e-06	2.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	5.12e-06	2.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	5.12e-06	2.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	5.09e-06	2.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.09e-06	2.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	5.08e-06	2.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	5.06e-06	2.03e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—AGT—epilepsy syndrome	5.05e-06	2.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	5.03e-06	2.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	5.01e-06	2.01e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	5e-06	2e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	4.99e-06	2e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	4.98e-06	2e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—APOE—epilepsy syndrome	4.95e-06	1.98e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	4.94e-06	1.98e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	4.93e-06	1.98e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	4.92e-06	1.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	4.92e-06	1.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	4.91e-06	1.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	4.9e-06	1.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	4.89e-06	1.96e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	4.89e-06	1.96e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	4.88e-06	1.96e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	4.87e-06	1.95e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	4.8e-06	1.93e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	4.79e-06	1.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	4.78e-06	1.92e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	4.78e-06	1.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ALB—epilepsy syndrome	4.77e-06	1.91e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	4.73e-06	1.9e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	4.73e-06	1.9e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	4.71e-06	1.89e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	4.68e-06	1.88e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	4.67e-06	1.87e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	4.65e-06	1.86e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	4.64e-06	1.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	4.59e-06	1.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	4.58e-06	1.84e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	4.58e-06	1.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	4.55e-06	1.82e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	4.55e-06	1.82e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	4.55e-06	1.82e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	4.54e-06	1.82e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	4.53e-06	1.82e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	4.5e-06	1.8e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	4.49e-06	1.8e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	4.49e-06	1.8e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	4.45e-06	1.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	4.45e-06	1.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	4.45e-06	1.78e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.44e-06	1.78e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	4.4e-06	1.77e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	4.39e-06	1.76e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	4.38e-06	1.75e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	4.36e-06	1.75e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	4.36e-06	1.75e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	4.31e-06	1.73e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.29e-06	1.72e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	4.28e-06	1.72e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.27e-06	1.71e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	4.27e-06	1.71e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	4.26e-06	1.71e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—POMC—epilepsy syndrome	4.25e-06	1.7e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	4.24e-06	1.7e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	4.23e-06	1.7e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	4.22e-06	1.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	4.21e-06	1.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	4.2e-06	1.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	4.2e-06	1.68e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	4.18e-06	1.68e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	4.18e-06	1.67e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	4.17e-06	1.67e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.17e-06	1.67e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	4.15e-06	1.67e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	4.14e-06	1.66e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	4.14e-06	1.66e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	4.13e-06	1.66e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	4.11e-06	1.65e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	4.05e-06	1.63e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	4.03e-06	1.62e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	4.01e-06	1.61e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	3.98e-06	1.6e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	3.91e-06	1.57e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	3.91e-06	1.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	3.9e-06	1.56e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	3.9e-06	1.56e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	3.89e-06	1.56e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	3.88e-06	1.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ALB—epilepsy syndrome	3.87e-06	1.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	3.87e-06	1.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	3.84e-06	1.54e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	3.84e-06	1.54e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	3.83e-06	1.54e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	3.82e-06	1.53e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	3.82e-06	1.53e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.81e-06	1.53e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	3.81e-06	1.53e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.78e-06	1.52e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	3.77e-06	1.51e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	3.74e-06	1.5e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	3.73e-06	1.5e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	3.73e-06	1.5e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	3.69e-06	1.48e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	3.63e-06	1.46e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	3.62e-06	1.45e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	3.6e-06	1.44e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	3.59e-06	1.44e-05	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	3.58e-06	1.44e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	3.55e-06	1.43e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	3.53e-06	1.42e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	3.52e-06	1.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	3.52e-06	1.41e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.5e-06	1.4e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.5e-06	1.4e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	3.48e-06	1.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	3.47e-06	1.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	3.47e-06	1.39e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	3.45e-06	1.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	3.39e-06	1.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.38e-06	1.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	3.37e-06	1.35e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.36e-06	1.35e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	3.35e-06	1.34e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	3.33e-06	1.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	3.28e-06	1.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.27e-06	1.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.26e-06	1.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	3.24e-06	1.3e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	3.23e-06	1.3e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.22e-06	1.29e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	3.21e-06	1.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	3.19e-06	1.28e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.18e-06	1.27e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	3.15e-06	1.26e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	3.15e-06	1.26e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	3.14e-06	1.26e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.14e-06	1.26e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	3.14e-06	1.26e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	3.1e-06	1.24e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	3.08e-06	1.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	3.06e-06	1.23e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.05e-06	1.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	3.02e-06	1.21e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	3.01e-06	1.21e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.97e-06	1.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.94e-06	1.18e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	2.92e-06	1.17e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.92e-06	1.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	2.92e-06	1.17e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	2.9e-06	1.16e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	2.89e-06	1.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	2.86e-06	1.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.86e-06	1.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	2.83e-06	1.14e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.83e-06	1.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	2.82e-06	1.13e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	2.81e-06	1.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	2.78e-06	1.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.75e-06	1.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.75e-06	1.1e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.73e-06	1.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.71e-06	1.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2.68e-06	1.07e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.66e-06	1.07e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.65e-06	1.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.63e-06	1.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.6e-06	1.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	2.56e-06	1.02e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	2.52e-06	1.01e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.49e-06	9.97e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.47e-06	9.89e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.45e-06	9.84e-06	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	2.43e-06	9.75e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.41e-06	9.67e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.4e-06	9.64e-06	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	2.38e-06	9.54e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.29e-06	9.19e-06	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	2.24e-06	8.96e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.23e-06	8.95e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.1e-06	8.41e-06	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	2.08e-06	8.34e-06	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.88e-06	7.53e-06	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.8e-06	7.23e-06	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.75e-06	7.03e-06	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.73e-06	6.92e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.7e-06	6.83e-06	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.57e-06	6.28e-06	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.53e-06	6.15e-06	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-06	5.71e-06	CbGpPWpGaD
